ICU Medical, Inc. (NASDAQ:ICUI) Shares Purchased by Gagnon Securities LLC

Gagnon Securities LLC boosted its stake in ICU Medical, Inc. (NASDAQ:ICUIFree Report) by 0.5% in the fourth quarter, Holdings Channel reports. The fund owned 28,881 shares of the medical instruments supplier’s stock after buying an additional 137 shares during the quarter. Gagnon Securities LLC’s holdings in ICU Medical were worth $4,481,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Allworth Financial LP boosted its stake in shares of ICU Medical by 100.0% during the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 100 shares during the last quarter. Equitable Trust Co. lifted its stake in ICU Medical by 2.2% in the third quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock valued at $950,000 after buying an additional 112 shares during the last quarter. Hexagon Capital Partners LLC lifted its stake in ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 122 shares during the last quarter. Connable Office Inc. raised its stake in shares of ICU Medical by 6.4% during the third quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier’s stock valued at $370,000 after purchasing an additional 122 shares in the last quarter. Finally, CIBC Asset Management Inc raised its stake in shares of ICU Medical by 9.8% during the third quarter. CIBC Asset Management Inc now owns 2,262 shares of the medical instruments supplier’s stock valued at $412,000 after purchasing an additional 201 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

Shares of ICUI stock opened at $164.36 on Friday. ICU Medical, Inc. has a 12 month low of $86.80 and a 12 month high of $196.26. The stock has a 50 day moving average of $160.98 and a 200-day moving average of $162.07. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ICUI. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a research note on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp lifted their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $199.67.

Get Our Latest Analysis on ICUI

Insider Activity

In other news, Director David C. Greenberg sold 972 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the sale, the director now owns 5,037 shares in the company, valued at approximately $796,400.07. This represents a 16.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Vivek Jain sold 12,000 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the sale, the chief executive officer now owns 104,593 shares in the company, valued at $17,039,245.63. The trade was a 10.29 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,737 shares of company stock worth $2,879,752. Company insiders own 6.70% of the company’s stock.

ICU Medical Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Further Reading

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUIFree Report).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.